Report Finds Substantial Variation In Health Board Prescribing Of GLP 1 Drugs
Report finds ‘substantial variation’ in health board prescribing of GLP-1 drugs A new report has highlighted “substantial geographical variation” in prescribing of drugs such as Ozempic and Mounjaro on the NHS in Scotland. The first study of its kind by the Association of the British Pharmaceutical Industry (ABPI) found that while there had been “strong
